Orion Oyj A (ORNAV.HE) — Quality & forensics
As of 2026-09-18 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.
The Closelook module scores
- Valuation 34
- Quality 83
- Growth 63
- Balance sheet 81
- Cash quality 27
- Capital allocation 47
- Momentum 78
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — above the −1.78 threshold the literature flags for earnings-manipulation risk. A screen, not an accusation.
Continue: the ORNAV.HE chart & overview
FAQ · from the current data · as of 2026-09-18
Quick answers
What is Orion Oyj A's Closelook quality reading?
The composite reads 62/100 across 7 modules, as of 2026-09-18: valuation 34, quality 83, growth 63, balance sheet 81, cash quality 27, capital allocation 47, momentum 78. Closelook scores are research diary readings, not ratings or investment advice.
What is Orion Oyj A's Altman Z-Score?
12.60, which sits in the safe zone (above 2.99) as of 2026-09-18. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Orion Oyj A's Piotroski F-Score?
6 of 9, as of 2026-09-18. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Orion Oyj A's Beneish M-Score indicate?
-1.29 — above the −1.78 threshold the literature flags for earnings-manipulation risk, as of 2026-09-18. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelook universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- ORNBV.HE Orion Oyj Bindustry
- SAN.PA Sanofi SAindustry
- NVO Novo Nordisk A/Sindustry
- AMGN Amgen Incindustry
- GRF.MC Grifols S.A.industry
- GILD Gilead Sciences Incindustry
- MRK Merck & Company Incindustry
- PFE Pfizer Incindustry
- ABBV AbbVie Incindustry
- JNJ Johnson & Johnsonindustry
- BIIB Biogen Incindustry
- OGN Organon & Coindustry
- BMY Bristol-Myers Squibb Companyindustry
- GSK GlaxoSmithKline PLC ADRindustry
- SNY Sanofi ADRindustry
- AZN AstraZeneca PLCindustry
- BION.SW BB Biotech AGsector
- DXCM DexCom Incsector
- ARGX.BR Argen-Xsector